MedPath

UNDA 38

UNDA 38

Discontinued
DIN Number

02233257

Drug Class

Human

Market Date

Apr 6, 1998

Company
HC

seroyal international inc.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02233257
AIG Number0632413001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Homeopathic
Product Specifications
Dosage FormPellet ,  Tablet ,  Granules ,  Drops ,  Liquid
Route of AdministrationOral
AHFS Classification92:02.00*
Health Canada Classification

ACTIVE INGREDIENTS (6)

ALUMINUMActive
Strength: 12 X
Monograph: ALUMINUM
INULA HELENIUMActive
Strength: 4 X
Monograph: INULA HELENIUM
SARSAPARILLAActive
Strength: 4 X
Monograph: SARSAPARILLA
SILVERActive
Strength: 12 X
Monograph: SILVER
VALERIANActive
Strength: 4 X
Monograph: VALERIAN
ZEA MAYSActive
Strength: 4 X
Monograph: ZEA MAYS

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.